106 related articles for article (PubMed ID: 24503485)
1. Inability of HOXB4 to enhance self-renewal of malignant B cells: favorable profile for the expansion of autologous hematopoietic stem cells.
Fournier M; Savoie-Rondeau I; Larochelle F; Hassawi M; Shestakova EA; Roy DC; Bijl JJ
Exp Hematol; 2014 Jul; 42(7):526-35.e4. PubMed ID: 24503485
[TBL] [Abstract][Full Text] [Related]
2. Effects of HOXB4 overexpression on ex vivo expansion and immortalization of hematopoietic cells from different species.
Zhang XB; Schwartz JL; Humphries RK; Kiem HP
Stem Cells; 2007 Aug; 25(8):2074-81. PubMed ID: 17510218
[TBL] [Abstract][Full Text] [Related]
3. Stromal cells selectively reduce the growth advantage of human committed CD34+ hematopoietic cells ectopically expressing HOXB4.
Friel J; Schiedlmeier B; Geldmacher M; Ostertag W
Growth Factors; 2006 Jun; 24(2):97-105. PubMed ID: 16801129
[TBL] [Abstract][Full Text] [Related]
4. Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness.
Hong SH; Yang SJ; Kim TM; Shim JS; Lee HS; Lee GY; Park BB; Nam SW; Ryoo ZY; Oh IH
Stem Cells; 2014 May; 32(5):1313-22. PubMed ID: 24446131
[TBL] [Abstract][Full Text] [Related]
5. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
Bourette RP; Grasset MF; Mouchiroud G
Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
[TBL] [Abstract][Full Text] [Related]
6. The HOXB4 homeoprotein differentially promotes ex vivo expansion of early human lymphoid progenitors.
Haddad R; Pflumio F; Vigon I; Visentin G; Auvray C; Fichelson S; Amsellem S
Stem Cells; 2008 Feb; 26(2):312-22. PubMed ID: 17962697
[TBL] [Abstract][Full Text] [Related]
7. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
[TBL] [Abstract][Full Text] [Related]
8. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein.
Krosl J; Austin P; Beslu N; Kroon E; Humphries RK; Sauvageau G
Nat Med; 2003 Nov; 9(11):1428-32. PubMed ID: 14578881
[TBL] [Abstract][Full Text] [Related]
9. [Regulatory role of HOXB4 in self-renewal of hematopoietic stem cells - review].
Zheng CL; Zhou B; Lu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):647-51. PubMed ID: 17605886
[TBL] [Abstract][Full Text] [Related]
10. The functional duality of HoxB4 in hematopoietic reconstituting cells.
Kaplan D; Kaye N; Liu F; Fu P; Margevicius S; Meyerson HJ; Lazarus HM
Cytometry A; 2013 Jan; 83(1):127-33. PubMed ID: 22522741
[TBL] [Abstract][Full Text] [Related]
11. Purified recombinant TAT-homeobox B4 expands CD34(+) umbilical cord blood and peripheral blood progenitor cells ex vivo.
Huang CH; Chen PM; Lu TC; Kung WM; Chiou TJ; Yang MH; Kao JY; Wu KJ
Tissue Eng Part C Methods; 2010 Jun; 16(3):487-96. PubMed ID: 19686058
[TBL] [Abstract][Full Text] [Related]
12. [Ex vivo expansion of human hematopoietic stem/progenitor cells by TAT-HOXB4 homeoprotein and the prospect of its clinical use].
Xu C; Chen H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):489-92. PubMed ID: 23628061
[TBL] [Abstract][Full Text] [Related]
13. Hoxa9/hoxb3/hoxb4 compound null mice display severe hematopoietic defects.
Magnusson M; Brun AC; Lawrence HJ; Karlsson S
Exp Hematol; 2007 Sep; 35(9):1421-8. PubMed ID: 17761289
[TBL] [Abstract][Full Text] [Related]
14. The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential.
Krosl J; Beslu N; Mayotte N; Humphries RK; Sauvageau G
Immunity; 2003 Apr; 18(4):561-71. PubMed ID: 12705858
[TBL] [Abstract][Full Text] [Related]
15. Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells.
Lu SJ; Feng Q; Ivanova Y; Luo C; Li T; Li F; Honig GR; Lanza R
Stem Cells Dev; 2007 Aug; 16(4):547-59. PubMed ID: 17784829
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size.
Thorsteinsdottir U; Sauvageau G; Humphries RK
Blood; 1999 Oct; 94(8):2605-12. PubMed ID: 10515864
[TBL] [Abstract][Full Text] [Related]
17. HOXB4-induced self-renewal of hematopoietic stem cells is significantly enhanced by p21 deficiency.
Miyake N; Brun AC; Magnusson M; Miyake K; Scadden DT; Karlsson S
Stem Cells; 2006 Mar; 24(3):653-61. PubMed ID: 16210402
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2.
Giannola DM; Shlomchik WD; Jegathesan M; Liebowitz D; Abrams CS; Kadesch T; Dancis A; Emerson SG
J Exp Med; 2000 Nov; 192(10):1479-90. PubMed ID: 11085749
[TBL] [Abstract][Full Text] [Related]
19. High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation.
Schiedlmeier B; Klump H; Will E; Arman-Kalcek G; Li Z; Wang Z; Rimek A; Friel J; Baum C; Ostertag W
Blood; 2003 Mar; 101(5):1759-68. PubMed ID: 12406897
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.
Yu H; Neale G; Zhang H; Lee HM; Ma Z; Zhou S; Forget BG; Sorrentino BP
Blood; 2014 Sep; 124(11):1737-47. PubMed ID: 25082879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
